ICON partners with Cytocom in a Phase 3 trial for Crohn's disease
February 16 2021 - 11:11AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Cytocom (NASDAQ:CBLI)
Historical Stock Chart
From Feb 2024 to Mar 2024
Cytocom (NASDAQ:CBLI)
Historical Stock Chart
From Mar 2023 to Mar 2024